Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Schrodinger Inc (SDGR)

Schrodinger Inc (SDGR)
17.48 x 2 20.27 x 2
Post-market by (Cboe BZX)
18.03 -0.84 (-4.45%) 04/04/25 [NASDAQ]
17.48 x 2 20.27 x 2
Post-market 18.03 unch (unch) 16:49 ET
Quote Overview for Fri, Apr 4th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
17.08
Day High
18.59
Open 18.06
Previous Close 18.87 18.87
Volume 1,608,300 1,608,300
Avg Vol 943,735 943,735
Stochastic %K 17.92% 17.92%
Weighted Alpha -38.68 -38.68
5-Day Change -1.93 (-9.67%) -1.93 (-9.67%)
52-Week Range 16.67 - 29.15 16.67 - 29.15
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,378,227
  • Shares Outstanding, K 73,038
  • Annual Sales, $ 207,540 K
  • Annual Income, $ -187,120 K
  • EBIT $ -209 M
  • EBITDA $ -203 M
  • 60-Month Beta 1.77
  • Price/Sales 7.00
  • Price/Cash Flow N/A
  • Price/Book 3.44

Options Overview Details

View History
  • Implied Volatility 94.96% ( +15.04%)
  • Historical Volatility 60.44%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 94.96% on 04/04/25
  • IV Low 48.41% on 05/17/24
  • Put/Call Vol Ratio 0.61
  • Today's Volume 603
  • Volume Avg (30-Day) 582
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 17,220
  • Open Int (30-Day) 20,011

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.71
  • Number of Estimates 3
  • High Estimate -0.70
  • Low Estimate -0.72
  • Prior Year -0.76
  • Growth Rate Est. (year over year) +6.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.08 +5.58%
on 04/04/25
Period Open: 21.08
23.90 -24.56%
on 03/17/25
-3.05 (-14.47%)
since 03/04/25
3-Month
17.08 +5.58%
on 04/04/25
Period Open: 20.87
28.47 -36.67%
on 02/18/25
-2.84 (-13.61%)
since 01/03/25
52-Week
16.67 +8.16%
on 10/08/24
Period Open: 26.05
29.15 -38.15%
on 04/09/24
-8.02 (-30.79%)
since 04/04/24

Most Recent Stories

More News
Healthcare AI Market to Surge 43% Annually—Key Stocks to Watch

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – The integration of artificial intelligence (AI) into the healthcare sector is accelerating at an unprecedented...

AVAI : 0.4100 (+0.74%)
ABSI : 2.28 (+2.01%)
SDGR : 18.03 (-4.45%)
MDAI : 1.2100 (-1.63%)
MDT : 82.88 (-5.70%)
AI Pharma: 2 Paths to AI-Powered Drug Investment

AI is transforming drug development, allowing companies to identify new drug targets, optimize clinical trials and speed delivery of medicines to patients.

LLY : 738.21 (-6.45%)
GPCR : 15.12 (-7.41%)
SDGR : 18.03 (-4.45%)
NVS : 105.85 (-5.71%)
RXRX : 4.24 (-11.85%)
Health AI Revolution: Experts Predict Major Advancements in AI-Powered Healthcare in 2025

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – Experts predict that artificial intelligence (AI) will soon transition from a novel concept in healthcare...

AVAI : 0.4100 (+0.74%)
GEHC : 60.51 (-15.96%)
SDGR : 18.03 (-4.45%)
MDAI : 1.2100 (-1.63%)
TEM : 42.58 (-7.78%)
3 Small-Cap Stocks to Invest in AI Drug Development

As AI continues to reshape the drug development landscape, here are three promising small-cap biotech stocks worth considering now.

RXRX : 4.24 (-11.85%)
SDGR : 18.03 (-4.45%)
EXAI : 4.84 (+3.20%)
NVDA : 94.31 (-7.36%)
What's the Difference Between Biotech Stocks and TechBio Stocks?

A few enterprising businesses are marketing themselves differently.

DNA : 5.57 (-2.28%)
RXRX : 4.24 (-11.85%)
SDGR : 18.03 (-4.45%)
6 Under-the-Radar AI Stocks That Analysts Expect to Rally

Morgan Stanley is betting on these stocks to benefit from the AI megatrend.

NVDA : 94.31 (-7.36%)
MSFT : 359.84 (-3.56%)
AMZN : 171.00 (-4.15%)
MS : 99.83 (-7.50%)
RXRX : 4.24 (-11.85%)
SDGR : 18.03 (-4.45%)
DH : 2.51 (+0.20%)
RBLX : 52.96 (-9.03%)
SRAD : 20.32 (-4.11%)
SPGI : 451.50 (-7.74%)
Billionaire Bill Gates Has 35% of His Portfolio Invested in These 2 Artificial Intelligence (AI) Stocks: Are They No-Brainer Buys?

AI is a key growth driver for both of these stocks owned by the Gates Foundation Trust.

MSFT : 359.84 (-3.56%)
SDGR : 18.03 (-4.45%)
3 AI-Driven Drug Stocks to Buy Before They Breakout

The pharma sector is expected to undergo a huge disruption, thanks to the impact of artificial intelligence. Here are three companies that Wall Street analysts think could benefit, based on their AI-driven...

NVDA : 94.31 (-7.36%)
GOOGL : 145.60 (-3.40%)
AMZN : 171.00 (-4.15%)
GS : 470.81 (-7.91%)
ABCL : 2.09 (unch)
REGN : 573.45 (-6.09%)
MRNA : 25.11 (-2.41%)
LLY : 738.21 (-6.45%)
NVS : 105.85 (-5.71%)
SDGR : 18.03 (-4.45%)
BMY : 55.30 (-3.32%)
ABSI : 2.28 (+2.01%)
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?

2024 is going to be a sizzler in the biopharma sector.

NVO : 62.55 (-6.78%)
LLY : 738.21 (-6.45%)
PFE : 22.97 (-5.43%)
AZN : 68.46 (-7.39%)
RXRX : 4.24 (-11.85%)
SDGR : 18.03 (-4.45%)
Is Schrödinger Stock a Buy Now?

Its groundbreaking work is winning it some powerful fans, but it's still risky.

LLY : 738.21 (-6.45%)
SDGR : 18.03 (-4.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Schr'dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr'dinger Inc. is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 20.23
2nd Resistance Point 19.41
1st Resistance Point 18.72
Last Price 18.03
1st Support Level 17.21
2nd Support Level 16.39
3rd Support Level 15.69

See More

52-Week High 29.15
Fibonacci 61.8% 24.38
Fibonacci 50% 22.91
Fibonacci 38.2% 21.44
Last Price 18.03
52-Week Low 16.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades